Kokam

Kokum (Garcinia indica): A Comprehensive Reference

1. Identity and Botanical Classification

1.1 Botanical and Scientific Names

Kokum, Garcinia indica (Choisy), belongs to the Clusiaceae family (also known as the mangosteen family) and is a tropical evergreen tree distributed in certain regions of India. The plant has also been referenced under the synonymous classification Garcinia indica Thouars Choisy and Brindonia indica. In English it is variously called wild mangosteen, kokam, Goa butter tree, or kokum butter tree. Regional and vernacular names include: Vrikshamia, Vrikshamla, Amlabija, Raktavrikshamla in Sanskrit; kokum in Hindi and Gujarati; bheranda in Marathi; punarpuli in Tulu; murgal in Tamil; kaattampi in Malayalam; Goraka in Sinhala; and bhirind in Konkani.

1.2 Botanical Description and Geographic Distribution

The evergreen kokum tree is found along the west coast of India and is known not only for its beauty but also for its use as a condiment. It is found principally in the western peninsular coastal regions, including the states of Maharashtra, Goa, Karnataka, and Kerala, and also in parts of Eastern India such as West Bengal, Assam, and the North-Eastern Hill regions. The trees yield fruits annually in the summer season during the months of March to May; the fruits are green when raw and red to dark purple when fully ripe.

1.3 Common Forms and Preparations

Every part of the kokum fruit is used in different forms. The principal commercial and culinary forms are:

• Dried rind: The dried rind, known as "kokum," is an Indian spice and condiment used in many parts of the country for making curry preparations.
• Kokum sherbet/juice: Juice (sherbet) made from the rind is used traditionally for piles, hemorrhoids, colic problems, and ulcers.
• Kokum agal (concentrate): A thick extract or concentrate (Kokum Agal) is made by grinding the fruit and straining the juice, commonly used in making Solkadhi and other beverages.
• Kokum butter: Oil is extracted from kokum seeds, known as kokum butter, and it is utilized in curries, cosmetics, pharmaceuticals, and expensive confectionery recipes.
• Powder and capsules: The dried fruit rind is ground to powder and is also available in encapsulated form as a dietary supplement.
• Wine and health drinks: It has been used in culinary and industrial applications for a variety of purposes, including as an acidulant in curries, pickles, health drinks, and wine.

Traditional methods for processing kokum and extracting its butter include sun drying, boiling, and hand-milling, while modern techniques include solvent extraction, supercritical fluid extraction, and enzymatic extraction.

2. Traditional and Historical Use

2.1 Ayurvedic Medicine

Kokum has a long history of use in the Indian traditional system of medicine, Ayurveda. The leaves and fruits are described as sour, astringent, thermogenic, constipating, and digestive. Herbal preparations made from kokum rinds are used in the treatment of inflammatory ailments, rheumatic pains, and bowel complaints. The fruit is considered to be anthelmintic and cardiotonic.

Traditionally, Garcinia fruits have been used in Ayurvedic medicine to treat ailments such as allergic rashes, burns, chafed skin, and scalds; to manage bleeding piles, tumors, and heart conditions; and as a tonic for heart and liver health. Ayurvedic practitioners have historically utilized kokum to heal wounds, dermatitis, diarrhea, dysentery, and ear infections, and to improve digestion.

In Ayurvedic classification, kokum butter has the following properties: Rasa (taste) — amla (sour) and madhura (sweet); Guna (qualities) — rooksha (dry) and guru (heavy to digest); Vipaka (taste conversion after digestion) — amla (sour); Veerya (potency) — ushna (hot).

2.2 Culinary and Folk Traditions

Kokum is a versatile ingredient in many regional Indian cuisines. In Goan and Maharashtrian dishes, it replaces tamarind to add sourness to fish curries and vegetable dishes. In Konkani cuisine, it is the key ingredient in Solkadhi, a pink, tangy digestive drink made with coconut milk. Kokum is also used in dal preparations, chutneys, sherbets, squashes, and syrups.

The kokum fruit's pH ranges from 1.5 to 2.0, which naturally gives it high acidity, accounting for its widespread use as a natural souring agent in lieu of tamarind or other acidulants. Its significant applications also include fish pickling (known as Colombo curing), preparing refreshing drinks, and the manufacture of cosmetics.

The National Medicinal Plant Board of India has identified kokum as one of 32 prioritized species of plants for promotion and development.

3. Key Constituents and Active Compounds

3.1 Overview of Phytochemical Profile

Garcinia indica (kokum) is a rich source of bioactive compounds such as phenolic acids, flavonoids, citric acids, and others. Six significant chemical components are present in kokum rind: hydroxycitric acid, anthocyanin pigment, garcinol, isogarcinol, xanthochymol, and ascorbic acid. Apart from HCA and garcinol, kokum contains other compounds like citric acid, malic acid, polyphenols, anthocyanin pigments, and ascorbic acid, all with potent antioxidant properties.

3.2 Garcinol

Garcinol is a yellow-colored, fat-soluble pigment found in the rinds of G. indica at a level of 2–3%, which can be separated from the fruit rinds by ethanol and hexane extraction. Chemically, it belongs to the polyisoprenylated benzophenone class. Garcinol shows powerful antioxidant activity because it contains both phenolic hydroxyl groups and a β-diketone moiety, and in this respect it structurally resembles curcumin.

Mechanism of anti-inflammatory action: Garcinol inhibited the free-radical DPPH and was shown to have antioxidant activity on arachidonic acid metabolism and nitric oxide radical synthesis, activities involved in inflammation and carcinogenesis. It effectively inhibited inducible nitric oxide synthase (iNOS) synthesis by suppressing the activation of nuclear factor NF-κB. In cell models, garcinol inhibited the production of pro-inflammatory cytokines including TNF-α, IL-8, IL-6, and IL-1β, as well as the pro-inflammatory mediators iNOS and COX-2. It also decreased secretion of TNF-α, IL-6, IL-1β, PGE2, and NO. These anti-inflammatory effects involved an alteration of the NF-κB signaling pathway, with downregulation of pIKKα/β, pIκBα, and pNF-κB, reducing the translocation of NF-κB from the cytosol into the nucleus.

Mechanism of anti-cancer action: Garcinol, a polyisoprenylated benzophenone obtained from G. indica, has been found to be an effective inhibitor of several key regulatory pathways (e.g., NF-κB, STAT3) in cancer cells, thereby being able to control malignant growth of solid tumours in vivo. It is also a natural histone acetyltransferase (HAT) inhibitor both in vitro and in vivo, suggesting its implication in a wide variety of diseases like cancer and AIDS.

Antibacterial action: Garcinol shows antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA), comparable to that of the antibiotic vancomycin.

3.3 Hydroxycitric Acid (HCA)

Hydroxycitric acid (HCA) is a physiologically active chemical that is used as an acidulant and has been demonstrated to drastically lower body weight. HCA is an active ingredient extracted from the rind of Indian Garcinia fruits; it inhibits adenosine triphosphate citrate lyase (ATP citrate lyase) and has been used in the treatment of obesity. By inhibiting ATP citrate lyase, HCA blocks the conversion of citrate to oxaloacetate and acetyl-CoA in the cytosol, thereby limiting the substrate available for de novo lipogenesis (fatty acid synthesis). This mechanism is considered responsible for its anti-obesity and lipid-lowering properties.

3.4 Anthocyanins

Among all bioactive compounds in kokum, garcinol, hydroxycitric acid, and anthocyanins — specifically cyanidin-3-glucoside and cyanidin-3-sambubioside — are the major identified compounds. These pigments are responsible for the deep red-purple color of the ripe fruit and contribute substantially to its antioxidant activity by scavenging free radicals and reactive oxygen species.

3.5 Kokum Butter Fatty Acid Composition

Kokum butter has a unique fatty acid composition with high levels of stearic and oleic acid, making it an ideal ingredient for skin and hair care products. Kokum butter typically contains approximately 1.0% linoleic acid, approximately 36.0% oleic acid, approximately 4.0% palmitic acid, and approximately 56.0% stearic acid. Its triglyceride composition is uniform, consisting of up to 80% of stearic-oleic-stearic (SOS) triglycerides.

4. Scientific Evidence by Area of Use

4.1 Antioxidant Activity

Antioxidant activity is among the most extensively documented properties of kokum extracts. Studies have demonstrated that kokum and its major compounds — garcinol, anthocyanins, and HCA — exhibit significant free radical scavenging activity. These studies have been conducted primarily in vitro (cell-free and cell-based assays). G. indica has demonstrated antioxidant, anti-obesity, anti-arthritic, anti-inflammatory, antibacterial, hepatoprotective, cardioprotective, antidepressant, and anxiolytic effects both in vitro and in vivo in preclinical research models. While the in vitro antioxidant evidence is robust, human clinical trials specifically evaluating antioxidant biomarkers in response to kokum supplementation remain limited.

4.2 Obesity and Weight Management

The anti-obesity evidence base for kokum's HCA content draws extensively from the broader Garcinia literature, since Garcinia indica (kokum) contains HCA at lower levels than the commercially studied species G. cambogia.

Systematic review and meta-analysis: A systematic review examined the efficacy of Garcinia extract (HCA) as a weight reduction agent using data from randomized clinical trials (RCTs); twelve trials were included out of twenty-three identified. Nine trials provided data suitable for statistical pooling, and the meta-analysis revealed a small, statistically significant difference in weight loss favouring HCA over placebo (mean difference: −0.88 kg; 95% CI: −1.75, −0.00). The authors noted that the magnitude of this effect was small and that all included trials had methodological limitations including short study durations and variable HCA salt formulations.

Clinical study: A clinical study on 100 obese individuals for a period of 3 months investigated the effects of HCA treatment; significant reductions in body weight, triceps, subscapular, and mid axillary measurements, as well as in serum triglyceride, cholesterol, HDL, and LDL levels, were observed following HCA dosage. This study was not placebo-controlled, limiting the strength of its conclusions.

Evidence strength: Overall, the weight loss evidence for HCA-containing Garcinia extracts is characterized as weak to modest. The effect size is small, trials are short-term, and the evidence primarily concerns G. cambogia (which contains higher HCA concentrations) rather than G. indica specifically. No large-scale, long-duration RCTs specific to kokum (G. indica) for obesity have been published.

4.3 Anti-Inflammatory and Anti-Arthritic Effects

G. indica has been used in traditional medicine to treat inflammation, dermatitis, and diarrhea. The anti-inflammatory evidence base is predominantly preclinical. In macrophage cell studies, garcinol inhibited the production of pro-inflammatory cytokines including TNF-α, IL-8, IL-6, and IL-1β, and decreased secretion of TNF-α, IL-6, IL-1β, PGE2, and NO. A rat model of adjuvant arthritis was used in preclinical studies on G. indica fruit extract, with results suggesting anti-arthritic potential. No human clinical trials specifically evaluating G. indica preparations for inflammatory conditions or arthritis have been published.

Evidence strength: Preliminary; in vitro and animal data only. No human RCT data for anti-inflammatory or anti-arthritic use.

4.4 Hepatoprotective Effects

In animal models treated with 800 mg/kg aqueous extracts of G. indica, slight or minimal fat changes were present around the dilated central vein and many regenerative cells were observed. This histology was similar to that of the silymarin-treated group (a proven hepatoprotective). These findings suggest that the hepatoprotective effect of aqueous extracts of G. indica in ethanol-induced hepatotoxicity may be due to increased endogenous antioxidant levels and the inhibition of lipid peroxidation in the liver.

Evidence strength: Preclinical (rodent) only. No controlled human data on hepatoprotection from G. indica specifically.

4.5 Cardioprotective Effects

A study evaluated the cardioprotective effect of aqueous extract of G. indica fruit rinds on isoprenaline-induced myocardial injury in Wistar albino rats. The study found limited evidence, and further studies with larger sample sizes and higher dose ranges were considered necessary. Preclinical studies have reported cardioprotective effects among the range of pharmacological activities demonstrated for G. indica.

Evidence strength: Preliminary animal data only; results from the cardioprotective rodent study were inconclusive.

4.6 Antidepressant and Anxiolytic Effects

Garcinia indica fruit rind was evaluated for antidepressant and anti-anxiety potential using the forced swim test, tail suspension test, and reserpine-induced hypothermia, and elevated plus maze, hole-board test, and light dark models. Garcinia indica fruit rind given to mice in food for 14 consecutive days at 0.5, 1, and 2% w/w significantly (p < 0.05) reduced despair behavior in the forced swim test, immobility duration in the tail suspension test, and also normalized reserpine-induced hypothermia.

It was concluded that the kokum was involved in adrenergic α1 receptor and dopamine D2-receptor pathways for its antidepressant effect. The use of monoaminergic pathway inhibitors (prazosin for α1-adrenoceptor, p-CPA for 5-HT synthesis, sulpiride for D2 dopamine) produced increases in immobility, with the effect attributed to declined noradrenergic activity, serotonin synthesis, and dopamine activity.

Evidence strength: Entirely animal (rodent) based. No human clinical trial data exist for antidepressant or anxiolytic applications of kokum.

4.7 Antimicrobial Effects

Preclinical studies have shown that kokum and/or some of its phytochemicals possess antibacterial, antifungal, and anti-ulcerogenic effects. Garcinol has shown antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA), comparable to the antibiotic vancomycin. In vitro antibacterial activity has also been reported against Salmonella typhi. No human clinical data support its use as an antimicrobial agent.

Evidence strength: In vitro and preclinical only.

4.8 Anticancer / Chemopreventive Effects

Numerous preclinical studies have reviewed the antitumor potential of garcinol in a variety of oncological variants, including colon and breast cancer models. Garcinol triggers apoptosis by inhibition of STAT3 and NF-κB pathways (anti-apoptotic pathways) and by downregulating anti-apoptotic protein Bcl-2 and upregulating Bax, which undergoes conformational change and translocates to the mitochondria, leading to cytochrome c release and activation of caspase-9, and subsequently caspase-3-mediated apoptosis. G. indica fruit and fruit rinds have been reported to have numerous therapeutic applications in various health conditions such as cancer, inflammation, diabetes, obesity, cardiovascular disease, and neurological disorders.

Evidence strength: All evidence is in vitro and animal-based. No human clinical trials have investigated kokum or garcinol as an anticancer agent in humans.

4.9 Skin Applications (Kokum Butter)

Kokum butter is solid at room temperature but slowly melts on contact with the skin, producing a non-oily emolliency; it is one of the most stable and hardest vegetable butters known and exhibits excellent emollient properties and high oxidative stability. The potential applications of kokum butter are vast, ranging across cosmetics, pharmaceuticals, and food industries.

In Ayurveda, kokum butter has been used for treating dryness of the skin, cracked lips, ulceration, mature skin conditions, oral diseases, and skin infections.

Evidence strength: The topical use of kokum butter in cosmetics is established at the industrial and traditional level. Controlled clinical studies evaluating its dermatological efficacy in human subjects are limited and were not identified in peer-reviewed literature for this article.

5. Body Systems and Health Areas of Association

• Digestive system: G. indica has been used in traditional medicine to promote digestion and to treat diarrhea. Kokum sherbet is traditionally consumed as a digestive aid.
• Metabolic / adipose: HCA content links kokum to fat synthesis inhibition via ATP citrate lyase and modest weight management effects in clinical data.
• Hepatic: Preclinical data indicate antioxidant-mediated hepatoprotection from ethanol-induced liver damage.
• Cardiovascular: Preclinical studies have attributed cardioprotective effects to G. indica.
• Central nervous system: Animal models demonstrate antidepressant and anxiolytic activity via monoaminergic pathways.
• Immune / inflammatory: Garcinol suppresses NF-κB-mediated inflammatory signaling in cell and animal models.
• Integumentary (skin): Kokum butter is widely used in topical preparations for moisturization, barrier repair, and traditional wound healing.
• Antimicrobial: In vitro activity against bacterial pathogens including MRSA.

6. Dosage Forms and Reported Dosages

Dosage data for kokum are derived from traditional practice, animal studies, and limited clinical research. Extrapolation from animal to human dosing has not been formally validated.

• Traditional/culinary (dried rind powder): A dose of 3–5 grams once or twice a day, before food, has been reported in traditional Ayurvedic practice.
• Juice preparation: Dried fruits soaked in water to prepare juice are administered in a dose of 100 ml, 2–3 times a day, in traditional practice.
• Capsule supplement: Kokum is also available in capsule form; a regular dose noted in practice is 1 capsule twice a day after food.
• Animal study dose (hepatoprotective): Doses of 400 mg/kg and 800 mg/kg aqueous extract were used in rodent hepatoprotective models, with 800 mg/kg producing results histologically comparable to silymarin.
• Animal study dose (antidepressant): Fruit rind was given to mice at 0.5, 1, and 2% w/w in food for 14 consecutive days in antidepressant and anxiolytic studies.
• HCA clinical dosing (Garcinia species, broader literature): A prospective clinical trial used 500 mg Garcinia extract (containing 52.4% HCA) twice per day for 6 months in 214 obese participants.

No standardized or regulatory-approved dosage has been established for kokum (G. indica) as a dietary supplement. Dosages from traditional practice should not be equated with clinically validated therapeutic doses.

7. Safety Considerations and Interactions

7.1 General Tolerability

In everyday culinary amounts, kokum is generally well tolerated. Concentrated extracts with garcinol have shown low toxicity in animal studies and were well tolerated in a short-term human trial when combined with curcuminoids and piperine.

Kokum may have side effects, but there are currently insufficient reports to clearly define what these might be; more research is needed to fully understand any adverse effects associated with its use.

7.2 Hepatotoxicity Risk (Garcinia Class Effect)

A notable safety concern exists within the broader Garcinia genus. In a prospective study conducted by the Drug Induced Liver Injury Network (DILIN), investigators identified 22 cases of drug-induced liver injury (DILI) associated with Garcinia among 1,987 patients from September 2004 through April 2018. Garcinia toxicity was consistent with drug-induced liver injury and included elevated serum liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase, with a high ratio of ALT to alkaline phosphatase. These cases were predominantly associated with G. cambogia-based weight-loss supplements rather than culinary use of G. indica, but the structural and chemical relatedness of the species warrants caution with high-dose concentrated extracts of any Garcinia species.

7.3 Potential Drug Interactions

Since kokum may act as a weight-reducing agent, it has the potential to affect substances involved in insulin sensitivity; it is important to exercise caution when combining kokum with such substances, and frequent monitoring may be necessary. Given the inhibitory effect of garcinol on the NF-κB and STAT3 signaling pathways, interactions with immunosuppressive drugs or chemotherapy agents are theoretically possible, though this has not been systematically studied in humans. The high acidity of kokum preparations (pH 1.5–2.0) may also affect the absorption of acid-sensitive medications.

7.4 Populations Requiring Caution

Those with liver, kidney, or gallbladder disease, or on polypharmacy, should exercise particular caution with supplemental dosing. Pregnant or breastfeeding individuals should also be cautious due to insufficient human safety data. People with a history of gastric sensitivity should note that the highly acidic nature of kokum beverages may aggravate acid reflux.

8. Overall Evidence Summary

Garcinia indica (kokum) is an underexplored fruit tree of the Western Ghats region that has been studied for its health benefits associated with numerous bioactive compounds, including phenolic acids, flavonoids, citric acids, and others. Its three principal bioactive classes — garcinol, HCA, and anthocyanins — each have mechanistic data from in vitro and animal research supporting antioxidant, anti-inflammatory, anti-obesity, hepatoprotective, antimicrobial, and neuroprotective activities. However, while preliminary studies emphasize potential health benefits, more research is needed to confirm these effects. The most human-relevant clinical evidence concerns HCA for weight management (derived from the broader Garcinia genus), where a 2011 meta-analysis of 12 RCTs showed a statistically significant but small weight loss effect. For all other therapeutic applications, the evidence is currently limited to in vitro and animal studies, and no large-scale, well-designed human RCTs have been conducted using G. indica specifically.

References

• Lim TK et al. "Pharmacological Activity of Garcinia indica (Kokum): An Updated Review." Pharmaceuticals. 2021;14(12):1338. PMC8708457.
• Lim TK et al. "Pharmacological Activity of Garcinia indica (Kokum): An Updated Review." MDPI Pharmaceuticals. 2021.
• Desai et al. "Bioactive compounds, bio-functional properties, and food applications of Garcinia indica: A review." Journal of Food Biochemistry. 2022.
• Baliga MS et al. "The chemistry and medicinal uses of the underutilized Indian fruit tree Garcinia indica Choisy (kokum): A review." Food Research International. 2011;44:1790–1799.
• Maurya SR et al. "Garcinia indica (Thouars) Choisy: Its Ethnobotanical Knowledge, Phytochemical Studies, Pharmacological Aspects, Future Prospect." Journal of Natural and Applied Sciences Pakistan. 2023;5(1):1192–1211.
• Panda V, Ashar H, Srinath S. "Antioxidant and hepatoprotective effect of Garcinia indica fruit rind in ethanol-induced hepatic damage in rodents." Interdisciplinary Toxicology. 2012;5:207–213.
• Onakpoya I et al. "The Use of Garcinia Extract (Hydroxycitric Acid) as a Weight loss Supplement: A Systematic Review and Meta-Analysis of Randomised Clinical Trials." Journal of Obesity. 2011;509038.
• Hayamizu K et al. "Effects of Garcinia cambogia (Hydroxycitric Acid) on visceral fat accumulation: a double-blind, randomized, placebo-controlled trial." PMC4053034.
• Asghar M et al. "A clinical and computational study on anti-obesity effects of hydroxycitric acid." RSC Advances. 2019.
• Dhamija I, Parle M, Kumar S. "Antidepressant and anxiolytic effects of Garcinia indica fruit rind via monoaminergic pathway." 3 Biotech. 2017;7:131. PMC5462661.
• Behera AK et al. "Garcinol and Its Role in Chronic Diseases." PubMed. 2016.
• Wirotesangthong M et al. "Anti-Inflammatory Effect of Garcinol Extracted from Garcinia dulcis via Modulating NF-κB Signaling Pathway." Nutrients. 2023;15(3):575. PMC9918937.
• Fakhruddin N et al. "Direct interaction of garcinol and related polyisoprenylated benzophenones…with the transcription factor STAT-1." PubMed. 2014.
• "Garcinol in gastrointestinal cancer prevention: recent advances and future prospects." Journal of Cancer Research and Clinical Oncology. Springer. 2024.
• "Hepatotoxicity of dietary supplements containing Garcinia gummi-gutta (L.) N. Robson." Pharmaceutical Biology. Taylor & Francis. 2025.
• "Exploring the Versatile Uses and Extraction Techniques of Kokum Butter: A Comprehensive Overview." Advances in Nutrition and Public Health. 2024.
• "Phytochemical Analysis of Kokum (Garcinia indica)." International Journal for Multidisciplinary Research. 2024.
• "Anxiolytic activity of aqueous extract of Garcinia indica in mice." ResearchGate.